Medical Packaging Films Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

出版日期: | 出版商: Mordor Intelligence Pvt Ltd | 英文 120 Pages | 商品交期: 2-3個工作天內



  • 全貌
  • 簡介
  • 目錄




第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 市場動態

  • 市場概要
  • 市場推動要素與法規的簡介
  • 市場推動因素
    • 生質塑膠材料的需求提升
    • 慢性疾病治療的需求提升
  • 市場阻礙因素
    • 原料價格的變動
  • 價值鏈分析
  • 波特的五力分析

第5章 市場區隔

  • 各材料類型
    • 塑膠膜
    • 金屬薄膜
  • 各應用領域
    • 袋子和小袋
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東和非洲

第6章 競爭情形

  • 企業簡介
    • Honeywell International Inc.
    • 3M Company
    • Wipak Oy
    • Amcor Plc
    • DuPont de Nemours, Inc.
    • Renolit Medical
    • PolyCine GmbH
    • Glenroy, Inc.
    • Toray Industries, Inc.
    • Klockner Pentaplast Group
    • Dunmore Corporation
    • Covestro AG

第7章 投資分析

第8章 市場機會及趨勢

Product Code: 68118

The medical packaging films market is predicted to witness a healthy CAGR of 4.5% over the forecast period (2021-2026). With the outbreak of new diseases and growth in regulatory norms across the world, the pharma sector focuses on population health management by which the growth in drugs and medical devices, augments the demand of medical packaging films.

Key Highlights

  • Moreover, as the sustainable technology continues to grow and become intrinsic to the business process, the medical technology sector is being tasked to incorporate sustainable technologies across its various sectors, with the packaging being a huge main factor. According to BioResources, in 2019, researchers conducted an experiment of Seaweed-based biodegradable films which were studied with the incorporation of different concentrations of neem (Azadirachta indica) leaf extract. The experiments indicated that the seaweed-based film incorporated with neem leaves extract has potential application as an active packaging material due to its enhanced mechanical properties and antimicrobial activity.
  • Also, the rising demand for bioplastic material in the packaging segment drives the market. In 2018, according to the European Bioplastics, the global volume production of bioplastics accounted for about 2.11 million metric tons, in which almost 65% of the volume was used in the packaging market segment. Various companies are moving towards sustainable packaging for the medical segment. In the past, Biome Bioplastics developed a cellulose-based compostable material (BiomeHT90) with 50% above content for biobased carbon content. The material can be processed through injection molding, sheet extrusion and thermoforming, and is suitable for medical instruments that require sterilization.
  • The growing demand to treat the chronic disease that requires continuous vaccination drives the market. Chronic diseases are the primary causes of death and disability globally. According to WHO, the estimated cases for the chronic disease may reach around 60% globally till 2020. As the vaccines for such cases are obtainable in pre-filled syringes form, its increased consumption is expected to boost the market growth especially for PP (Polypropylene) and PE (Polyethylene) films.
  • Fluctuation in the prices of raw materials restraints the growth of the market. Due to rising crude oil prices and robust consumption from plastic manufacturers, the prices get fluctuated by which the decrease in production rate challenge the market to grow.

Key Market Trends

Plastic to Gain Significant market Share in PC (Polycarbonate) Films in Medical Devices

  • Packaging for medical devices is generally fabricated from thermoformed Polycarbonate (PC) film, which refers to a polymer-based medical devices packaging. Such films provide the package and its contents to be sterilized together by exposure to radiation. Emerging applications of PC through thermoformed include various medical parts such as inhalers for the consumer market, ophthalmic products, orthopedic materials, lab-on-a-chip devices for determining blood chemistry or analyzing proteins, etc.
  • Autoclaving sterilization is the most common method to sterilize the equipment, where the equipment needs to withstand temperatures of up to 163 degrees Celsius. PC film is the most appropriate film to withstand this temperature.
  • LEXAN 8040 PC film of Tekra provides autoclave stability which meets sterile medical packaging applications complied by FDA regulations and USP-VI compliance. It maintains exceptional clarity while allowing heat resistance for steam and dry heat sterilization. The applications include ophthalmic solutions, blister packaging, implants, instrument tray sets, woven products, and diagnostics, which majorly increase the demand in the market.
  • Moreover, companies are focusing to implement this packaging films in various types of medical transplants. For instance, in Dec 2019, Covestro designed Makrofol MA507 polycarbonate film for packaging breast implants, as these are sensitive products that should arrive undamaged at the hospital after manufacture, sterilization, and transport. This PC film is highly transparent so the physician can reliably visually inspect the implant before unpacking it and are also characterized by high tear and impact resistance.

Asia-Pacific Witness a Significant Growth

  • Asia-Pacific is apprehended to be the fastest-growing market. With the rapid penetration of major companies operating in the pharmaceutical industry, rapid urbanization, improved health care services, rapid adoption of contract packaging in the pharmaceutical industry and the stringent regulations in opposition to counterfeit medicines are predicted to fuel the growth of this market in Asia-Pacific.
  • The increased frequency of kidney disease in Asia has given rise to the requirement for a host of therapies, including sophisticated devices to enhance treatment. The occurrence of kidney disease in Asia is growing even more due to increasing rates of diabetes and hypertension.
  • According to MedTech Intelligence, the demand for dialysis in India is growing at a rate of about 30% each year. The value of the dialysis market there has increased from USD 100 million in 2007 to more than USD 200 million. In China, alone, over 100,000 patients are treated and served with continuous ambulatory peritoneal dialysis. These statistics clearly enhance the demand for dialysis bags in these countries which are mainly being packaged in PVC films.
  • Moreover, according to the International Trade Administration, the market size for medical devices is increasing exponentially in the Asia-Pacific region. In 2019, the market size was USD 82.9 billion wherein 2020 the estimation of market size is estimated to be USD 88.6 billion. These stats say that the demand is high for especially PE (Polyethylene) film which is majorly being used for packaging devices due to its heat sealing properties.

Competitive Landscape

The medical packaging films market is fragmented in nature and the major players have used various strategies such as new product launches, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market, which increases the rivalry in the market. Key players are Honeywell, 3M, Amcor, etc. Recent developments in the market are -

  • Jun 2019 - Tekni-Plex ended up with the acquisition of three manufacturing facilities from Amcor's Flexible Packaging business unit. These three facilities located in Madison, Wisconsin, and Ashland in the United States, provide a wider portfolio of sterilizable medical device packaging substrates, which includes coated and uncoated Tyvek, heat-seal and cold-seal coated paper and films with medical-grade laminates.
  • Sep 2019 - At Pack Expo Las Vegas, Tekni-Films introduced TekniMD PX films, which is a series of proprietary high-performance, thermoformable copolyester films that provide an alternative to PETG for medical device packaging. These standard PX film is suitable for form, fill and seal applications, while PX MED has superior characteristics and is used as a substitute for silicone-coated PETG.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support



  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study




  • 4.1 Market Overview
  • 4.2 Introduction to Market Drivers and Restraints
  • 4.3 Market Drivers
    • 4.3.1 Rising Demand for Bioplastic Material
    • 4.3.2 Growing Demand to Treat Chronic Disease
  • 4.4 Market Restraints
    • 4.4.1 Fluctuation in the Prices of Raw Materials
  • 4.5 Value Chain Analysis
  • 4.6 Industry Attractiveness - Porter's Five Force Analysis
    • 4.6.1 Threat of New Entrants
    • 4.6.2 Bargaining Power of Buyers/Consumers
    • 4.6.3 Bargaining Power of Suppliers
    • 4.6.4 Threat of Substitute Products
    • 4.6.5 Intensity of Competitive Rivalry


  • 5.1 By Material Type
    • 5.1.1 Plastic Film
      • PE
      • PP
      • PVC
      • PC
    • 5.1.2 Metallic Film
  • 5.2 By Application
    • 5.2.1 Bags & Pouches
    • 5.2.2 Tubes
    • 5.2.3 Other Applications
  • 5.3 Geography
    • 5.3.1 North America
    • 5.3.2 Europe
    • 5.3.3 Asia-Pacific
    • 5.3.4 Latin America
    • 5.3.5 Middle-East and Africa


  • 6.1 Company Profiles
    • 6.1.1 Honeywell International Inc.
    • 6.1.2 3M Company
    • 6.1.3 Wipak Oy
    • 6.1.4 Amcor Plc
    • 6.1.5 DuPont de Nemours, Inc.
    • 6.1.6 Renolit Medical
    • 6.1.7 PolyCine GmbH
    • 6.1.8 Glenroy, Inc.
    • 6.1.9 Toray Industries, Inc.
    • 6.1.10 Klockner Pentaplast Group
    • 6.1.11 Dunmore Corporation
    • 6.1.12 Covestro AG